The Asia Pacific Large Molecule Drug Substance CDMO Market would witness market growth of 9.1% CAGR during the forecast period (2022-2028).
The demand for biologics and generic drugs is increasing exponentially, which has also propelled high competition in the pharmaceutical industry. The benefit of increased competition resulted in increased the pace of technological innovations increased. The downside to this was rising cost constraints.
As a result, the pharmaceutical industry’s dependence on CDMOs has increased to aid in overcoming many limitations. Through CDMOs, the pharmaceutical industry can progress its clinical candidate development, candidate registration, market authorization, and manufacturing. Many companies in the industry have also revisited their troublesome production operations to manage company assets and resources effectively.
This has helped the companies to regulate their finances. Additionally, CDMOs are able to provide cost-effective manufacturing and development services. Therefore, outsourcing development and manufacturing processes to a CDMO helps pharmaceutical companies increase their technical abilities without the restriction of rethinking equipment prices.
In this region, CDMOs providing services for the processing and development of biologics is growing. This growth is primarily influenced by the region’s massive and growing elderly proportion, who are demanding for better performing medicines. Additionally, in comparison to western regions, the affordability of biopharmaceuticals is high the Asia Pacific region. The emergence of biosimilars, which are low-cost generic variants of biologics, are driving up the investments for the regional CDMOs.
The China market dominated the Asia Pacific Large Molecule Drug Substance CDMO Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,965.8 million by 2028. The Japan market is estimated to grow a CAGR of 8.5% during (2022 - 2028). Additionally, The India market would experience a CAGR of 9.8% during (2022 - 2028).
Based on Application, the market is segmented into Mammalian, Microbial and Others. Based on Service, the market is segmented into Contract Manufacturing and Contract Development. Based on Contract Manufacturing Type, the market is segmented into Commercial and Clinical. Based on Contract Development Type, the market is segmented into Cell Line Development and Process Development. Based on End-user, the market is segmented into Biotech Companies, CRO and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Large Molecule Drug Substance CDMO Market is Projected to reach USD 19.2 Billion by 2028, at a CAGR of 8.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eurofins Scientific SE, WuXi Biologics (Cayman), Inc, Catalent, Inc., Boehringer Ingelheim International GmbH, FUJIFILM Diosynth Biotechnologies Texas LLC (Fujifilm Corporation), Samsung Biologics Co., Ltd. (Samsung Group), Rentschler Biopharma SE, AGC Biologics, Inc. (AGC, Inc.), Recipharm AB (EQT AB), and Siegfried Holding AG.
Scope of the Study
Market Segments Covered in the Report:
By Application
By Service
- Contract Manufacturing
- Contract Development
- Cell Line Development
- Process Development
By End-user
- Biotech Companies
- CRO
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Eurofins Scientific SE
- WuXi Biologics (Cayman), Inc
- Catalent, Inc.
- Boehringer Ingelheim International GmbH
- FUJIFILM Diosynth Biotechnologies Texas LLC (Fujifilm Corporation)
- Samsung Biologics Co., Ltd. (Samsung Group)
- Rentschler Biopharma SE
- AGC Biologics, Inc. (AGC, Inc.)
- Recipharm AB (EQT AB)
- Siegfried Holding AG
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Large Molecule Drug Substance CDMO Market, by Application
1.4.2 Asia Pacific Large Molecule Drug Substance CDMO Market, by Service
1.4.3 Asia Pacific Large Molecule Drug Substance CDMO Market, by End-user
1.4.4 Asia Pacific Large Molecule Drug Substance CDMO Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisition and Mergers
3.2.3 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Apr– 2022, Oct) Leading Players
3.3.3 Key Strategic Move: (Acquisitions and Mergers : 2018, Oct – 2022, Aug) Leading Players
Chapter 4. Asia Pacific Large Molecule Drug Substance CDMO Market by Application
4.1 Asia Pacific Mammalian Market by Country
4.2 Asia Pacific Microbial Market by Country
4.3 Asia Pacific Other Application Market by Country
Chapter 5. Asia Pacific Large Molecule Drug Substance CDMO Market by Service
5.1 Asia Pacific Contract Manufacturing Market by Country
5.2 Asia Pacific Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
5.2.1 Asia Pacific Commercial Market by Country
5.2.2 Asia Pacific Clinical Market by Country
5.3 Asia Pacific Contract Development Market by Country
5.4 Asia Pacific Large Molecule Drug Substance CDMO Market by Contract Development Type
5.4.1 Asia Pacific Cell Line Development Market by Country
5.4.2 Asia Pacific Process Development Market by Country
Chapter 6. Asia Pacific Large Molecule Drug Substance CDMO Market by End-user
6.1 Asia Pacific Biotech Companies Market by Country
6.2 Asia Pacific CRO Market by Country
6.3 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Large Molecule Drug Substance CDMO Market by Country
7.1 China Large Molecule Drug Substance CDMO Market
7.1.1 China Large Molecule Drug Substance CDMO Market by Application
7.1.2 China Large Molecule Drug Substance CDMO Market by Service
7.1.2.1 China Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.1.2.2 China Large Molecule Drug Substance CDMO Market by Contract Development Type
7.1.3 China Large Molecule Drug Substance CDMO Market by End-user
7.2 Japan Large Molecule Drug Substance CDMO Market
7.2.1 Japan Large Molecule Drug Substance CDMO Market by Application
7.2.2 Japan Large Molecule Drug Substance CDMO Market by Service
7.2.2.1 Japan Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.2.2.2 Japan Large Molecule Drug Substance CDMO Market by Contract Development Type
7.2.3 Japan Large Molecule Drug Substance CDMO Market by End-user
7.3 India Large Molecule Drug Substance CDMO Market
7.3.1 India Large Molecule Drug Substance CDMO Market by Application
7.3.2 India Large Molecule Drug Substance CDMO Market by Service
7.3.2.1 India Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.3.2.2 India Large Molecule Drug Substance CDMO Market by Contract Development Type
7.3.3 India Large Molecule Drug Substance CDMO Market by End-user
7.4 South Korea Large Molecule Drug Substance CDMO Market
7.4.1 South Korea Large Molecule Drug Substance CDMO Market by Application
7.4.2 South Korea Large Molecule Drug Substance CDMO Market by Service
7.4.2.1 South Korea Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.4.2.2 South Korea Large Molecule Drug Substance CDMO Market by Contract Development Type
7.4.3 South Korea Large Molecule Drug Substance CDMO Market by End-user
7.5 Singapore Large Molecule Drug Substance CDMO Market
7.5.1 Singapore Large Molecule Drug Substance CDMO Market by Application
7.5.2 Singapore Large Molecule Drug Substance CDMO Market by Service
7.5.2.1 Singapore Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.5.2.2 Singapore Large Molecule Drug Substance CDMO Market by Contract Development Type
7.5.3 Singapore Large Molecule Drug Substance CDMO Market by End-user
7.6 Malaysia Large Molecule Drug Substance CDMO Market
7.6.1 Malaysia Large Molecule Drug Substance CDMO Market by Application
7.6.2 Malaysia Large Molecule Drug Substance CDMO Market by Service
7.6.2.1 Malaysia Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.6.2.2 Malaysia Large Molecule Drug Substance CDMO Market by Contract Development Type
7.6.3 Malaysia Large Molecule Drug Substance CDMO Market by End-user
7.7 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market
7.7.1 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market by Application
7.7.2 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market by Service
7.7.2.1 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type
7.7.2.2 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market by Contract Development Type
7.7.3 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market by End-user
Chapter 8. Company Profiles
8.1 Teledyne FLIR LLC (Teledyne Technologies Incorporated)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Recent strategies and developments:
8.1.4.1 Partnerships, Collaborations and Agreements:
8.1.4.2 Product Launches and Product Expansions:
8.1.5 SWOT Analysis
8.2 Hikvision Digital Technology Co., Ltd., (China Electronics Technology Group Corporation)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Research & Development Expenses
8.2.4 Recent strategies and developments:
8.2.4.1 Partnerships, Collaborations, and Agreements:
8.2.4.2 Product Launches and Product Expansions:
8.3 Axis Communications AB (Canon, Inc.)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 Bosch Security Systems GmbH (Robert Bosch GmbH)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 Avigilon Corporation (Motorola Solutions)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional & Segmental Analysis
8.5.4 Research & Development Expenses
8.6 Hanwha Techwin Co., Ltd. (Hanwha Group)
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.6.2.2 Product Launches and Product Expansions:
8.7 Zhejiang Dahua Technology Co., Ltd.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Zhejiang Uniview Technologies Co., Ltd. (Hangzhou Jiaozhi Technology Co., Ltd.)
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
TABLE 1 Asia Pacific Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Large Molecule Drug Substance CDMO Market
TABLE 4 Acquisition and Mergers– Large Molecule Drug Substance CDMO Market
TABLE 5 Geographical Expansions – Large Molecule Drug Substance CDMO Market
TABLE 6 Asia Pacific Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 7 Asia Pacific Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 8 Asia Pacific Mammalian Market by Country, 2018 - 2021, USD Million
TABLE 9 Asia Pacific Mammalian Market by Country, 2022 - 2028, USD Million
TABLE 10 Asia Pacific Microbial Market by Country, 2018 - 2021, USD Million
TABLE 11 Asia Pacific Microbial Market by Country, 2022 - 2028, USD Million
TABLE 12 Asia Pacific Other Application Market by Country, 2018 - 2021, USD Million
TABLE 13 Asia Pacific Other Application Market by Country, 2022 - 2028, USD Million
TABLE 14 Asia Pacific Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 15 Asia Pacific Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 16 Asia Pacific Contract Manufacturing Market by Country, 2018 - 2021, USD Million
TABLE 17 Asia Pacific Contract Manufacturing Market by Country, 2022 - 2028, USD Million
TABLE 18 Asia Pacific Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 19 Asia Pacific Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 20 Asia Pacific Commercial Market by Country, 2018 - 2021, USD Million
TABLE 21 Asia Pacific Commercial Market by Country, 2022 - 2028, USD Million
TABLE 22 Asia Pacific Clinical Market by Country, 2018 - 2021, USD Million
TABLE 23 Asia Pacific Clinical Market by Country, 2022 - 2028, USD Million
TABLE 24 Asia Pacific Contract Development Market by Country, 2018 - 2021, USD Million
TABLE 25 Asia Pacific Contract Development Market by Country, 2022 - 2028, USD Million
TABLE 26 Asia Pacific Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 27 Asia Pacific Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 28 Asia Pacific Cell Line Development Market by Country, 2018 - 2021, USD Million
TABLE 29 Asia Pacific Cell Line Development Market by Country, 2022 - 2028, USD Million
TABLE 30 Asia Pacific Process Development Market by Country, 2018 - 2021, USD Million
TABLE 31 Asia Pacific Process Development Market by Country, 2022 - 2028, USD Million
TABLE 32 Asia Pacific Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 33 Asia Pacific Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 34 Asia Pacific Biotech Companies Market by Country, 2018 - 2021, USD Million
TABLE 35 Asia Pacific Biotech Companies Market by Country, 2022 - 2028, USD Million
TABLE 36 Asia Pacific CRO Market by Country, 2018 - 2021, USD Million
TABLE 37 Asia Pacific CRO Market by Country, 2022 - 2028, USD Million
TABLE 38 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 39 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 40 Asia Pacific Large Molecule Drug Substance CDMO Market by Country, 2018 - 2021, USD Million
TABLE 41 Asia Pacific Large Molecule Drug Substance CDMO Market by Country, 2022 - 2028, USD Million
TABLE 42 China Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 43 China Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 44 China Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 45 China Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 46 China Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 47 China Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 48 China Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 49 China Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 50 China Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 51 China Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 52 China Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 53 China Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 54 Japan Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 55 Japan Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 56 Japan Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 57 Japan Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 58 Japan Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 59 Japan Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 60 Japan Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 61 Japan Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 62 Japan Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 63 Japan Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 64 Japan Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 65 Japan Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 66 India Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 67 India Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 68 India Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 69 India Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 70 India Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 71 India Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 72 India Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 73 India Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 74 India Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 75 India Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 76 India Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 77 India Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 78 South Korea Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 79 South Korea Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 80 South Korea Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 81 South Korea Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 82 South Korea Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 83 South Korea Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 84 South Korea Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 85 South Korea Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 86 South Korea Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 87 South Korea Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 88 South Korea Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 89 South Korea Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 90 Singapore Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 91 Singapore Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 92 Singapore Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 93 Singapore Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 94 Singapore Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 95 Singapore Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 96 Singapore Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 97 Singapore Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 98 Singapore Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 99 Singapore Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 100 Singapore Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 101 Singapore Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 102 Malaysia Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 103 Malaysia Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 104 Malaysia Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 105 Malaysia Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 106 Malaysia Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 107 Malaysia Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 108 Malaysia Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 109 Malaysia Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 110 Malaysia Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 111 Malaysia Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 112 Malaysia Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 113 Malaysia Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 114 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market, 2018 - 2021, USD Million
TABLE 115 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market, 2022 - 2028, USD Million
TABLE 116 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market by Application, 2018 - 2021, USD Million
TABLE 117 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market by Application, 2022 - 2028, USD Million
TABLE 118 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market by Service, 2018 - 2021, USD Million
TABLE 119 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market by Service, 2022 - 2028, USD Million
TABLE 120 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2018 - 2021, USD Million
TABLE 121 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market by Contract Manufacturing Type, 2022 - 2028, USD Million
TABLE 122 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market by Contract Development Type, 2018 - 2021, USD Million
TABLE 123 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market by Contract Development Type, 2022 - 2028, USD Million
TABLE 124 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market by End-user, 2018 - 2021, USD Million
TABLE 125 Rest of Asia Pacific Large Molecule Drug Substance CDMO Market by End-user, 2022 - 2028, USD Million
TABLE 126 Key Information – Teledyne FLIR LLC
TABLE 127 Key Information – Hikvision Digital Technology Co., Ltd.,
TABLE 128 Key Information – Axis Communications AB
TABLE 129 Key Information – Bosch Security Systems GmbH
TABLE 130 Key Information – Avigilon Corporation
TABLE 131 Key Information – Hanwha Techwin Co., Ltd.
TABLE 132 Key Information – Zhejiang Dahua Technology Co., Ltd.
TABLE 133 Key Information – Zhejiang Uniview Technologies Co., Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, APR – 2022, Oct) Leading Players
FIG 5 Key Strategic Move: (Acquisitions and Mergers : 2018, Oct – 2022, Aug) Leading Players
FIG 6 Recent strategies and developments: Teledyne FLIR LLC
FIG 7 Swot analysis: Teledyne FLIR LLC
FIG 8 Recent strategies and developments: Hikvision Digital Technology Co., Ltd.
FIG 9 Recent strategies and developments: Axis Communications AB
FIG 10 Recent strategies and developments: Hanwha Techwin Co., Ltd.